+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-06-01Number of Pages: 248

Apheresis Market (Product - Devices and Disposables; Application - Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases, and Cardiovascular Diseases; Procedure - Plasmapheresis, Photopheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, and Erythrocytapheresis; Technology - Centrifugation and Membrane Filtration; End User - Private Blood Collection Centers, Public Blood Collection Centers, and Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Apheresis Market: Snapshot

Apheresis procedures have been performed since 1950’s for various blood purification and blood component separation purpose. Apheresis is a procedure of blood component separation using centrifugation or membrane filtration technology. This procedure is performed either for donation of a blood component or for treatment of a disease by removal of the diseased or disease causing blood component. Whole blood is extracted from donor or patient’s body, processed through apheresis machine, and the desired blood components are separated based on their molecular weight, size, and affinity for particular substance. The remaining blood is transfused back to donor or patient’s body. Apheresis procedures are performed across the globe for treatment of various neurological, renal, hematological, autoimmune and other disease.

In the past few years, apheresis procedures have witnessed a stark rise in the number and areas of applications and the global market for these procedures continues to rise at an excellent pace. Presently, a variety of apheresis procedures are widely used as a part of treatment in various renal, neurology, hematology, cardiovascular and autoimmune diseases. Transparency Market Research states that the global apheresis market was valued at US$1.85 Bn. The market is projected to expand at a CAGR of 10.2% from 2017 to 2025 and reach US$ 4.33 Bn by 2025. 

global apheresis market

Photopheresis Procedures to Witness Most Promising Rise in Demand

In terms of procedure, the global apheresis market is segmented in the report into plasmapheresis, photopheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis and others. Of these, the segment of plasmapheresis dominated the global apheresis market in terms of revenue contribution in 2016, chiefly owing to high number of donor plasmapheresis procedures undertaken every year global and the vast of applications of therapeutic plasma exchange.  The segment is also projected account for a notable share in the global market over the report’s forecast period and expand at a CAGR of 8.9% from 2017 to 2025. 

However, the segment of photopheresis is expected to lead in terms of rate of growth as the segment is projected to exhibit an excellent 12.2% CAGR from 2017 and 2025. The vast technological advancements observed in the field of photophersis in the past few years have led to a vast rise in the procedure’s vast applications in areas such as cancer and hematology disease treatment. 

North America to Retain Dominance, Asia Pacific to Exhibit Massive Growth Potential

From a geographical standpoint, the global apheresis market has been segmented in the report into five regions: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America dominated the global apheresis market in 2016 owing to its well-established healthcare infrastructure and high demand for plasma for production of plasma derived medicines. Disposables products segment is anticipated to contribute largest share in North America apheresis market. 

Asia Pacific, with its considerably established apheresis market in countries such as Japan and emerging economies such as India and China, is projected to witness exponential growth during the forecast period. The regional market is expected to exhibit an excellent CAGR of 11.2% from 2017 to 2025. Factors such as the vast rise in the prevalence of chronic diseases, high geriatric population, and increasing healthcare expenditure in this region will play the key role in upping the demand for apheresis procedures in the next few years. 

Some of the leading players operating in the global apheresis market are Asahi Kasei Medical Co. Ltd., Terumo Corporation, Haemonetics Corporation, Fresenius Kabi AG, Cerus Corporation, B. Braun Melsungen AG, Kawasumi Laboratories Inc., NIKKISO CO., LTD., Therakos, Inc., and Medica S.p.A.

1.Preface
    1.1.Market Definition and Scope
    1.2.Market Segmentation
    1.3.Key Research Objectives
    1.4.Research Highlights

2.Assumptions and Research Methodology

3.Executive Summary

4.Market Definition
    4.1.Introduction
           4.1.1.Product/Service Definition
           4.1.2.Industry Evolution / Developments
    4.2.Market Overview
    4.3.Key Market Indicators
           4.3.1.Global Health Care Expenditure Scenario
    4.4.Market Dynamics
           4.4.1.Drivers
           4.4.2.Restraints
           4.4.3.Opportunities
    4.5.Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, 2016 – 2024
           4.5.1.Market Revenue Projections (US$ Mn)
    4.6.Apheresis Market (Therapeutic Apheresis & Donor Apheresis) - Global Supply Demand Scenario
    4.7.Porter’s Five Force Analysis
    4.8.Event Impact Analysis
    4.9.Market Outlook

5.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Product Type
    5.1.Introduction & Definition
    5.2.Key Findings / Developments
    5.3.Key Trends
    5.4. Market Size (US$ Mn) Forecast By Product Type
           5.4.1.Devices
           5.4.2.Disposables
    5.5. Market Attractiveness By Product Type

6.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, By Application
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Key Trends
    6.4. Market Size (US$ Mn) Forecast, By Application
           6.4.1.Renal diseases
           6.4.2.Neurology
           6.4.3.Hematology
           6.4.4.Cancer
           6.4.5.Autoimmune disease 
           6.4.6.Cardiovascular diseases 
           6.4.7.Others (e.g. Fibrosis, Diabetes, Dermatology etc.)
    6.5. Comparison Matrix
    6.6. Market Attractiveness By Application

7.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Procedure
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Key Trends
    7.4. Market Size (US$ Mn) Forecast By Procedure
           7.4.1.Plasmapheresis
           7.4.2.Photopheresis
           7.4.3.LDL-apheresis
           7.4.4.Plateletpheresis
           7.4.5.Leukapheresis
           7.4.6.Erythrocytapheresis
           7.4.7.Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.)
    7.5. Comparison Matrix
    7.6. Market Attractiveness By Procedure 

8.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Technology
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Key Trends
    8.4. Market Size (US$ Mn) Forecast By Technology
           8.4.1.Centrifugation
           8.4.2.Membrane filtration
    8.5. Comparison Matrix
    8.6. Market Attractiveness By Technology

9.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By End-User
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Key Trends
    9.4. Market Size (US$ Mn) Forecast By End-User
           9.4.1. Hospitals 
           9.4.2. Blood Collection Centers
                    9.4.2.1.Public
                    9.4.2.2.private
    9.5. Comparison Matrix
    9.6. Market Attractiveness By End-User

10.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Region
    10.1. Key Findings
    10.2. Policies and Regulations
    10.3. Market Size (US$ Mn) Forecast By Region
           10.3.1. North America
           10.3.2. Europe
           10.3.3. Asia Pacific
           10.3.4. Latin America
           10.3.5. Middle East & Africa
    10.4. Market Attractiveness By Country/Region

11.North America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
    11.1. Introduction & Definition
    11.2. Key Findings / Developments
    11.3. Key Trends
    11.4. Market Size (US$ Mn) Forecast, By Country
           11.4.1. U.S.
           11.4.2. Canada
    11.5. Market Size (US$ Mn) Forecast By Product Type
           11.5.1. Devices
           11.5.2.Disposables
    11.6. Market Size (US$ Mn) Forecast, By Application
           11.6.1. Renal diseases
           11.6.2. Neurology
           11.6.3. Hematology
           11.6.4. Cancer
           11.6.5. Autoimmune disease 
           11.6.6. Cardiovascular diseases 
           11.6.7. Others 
    11.7. Market Size (US$ Mn) Forecast By Procedure
           11.7.1. Plasmapheresis
           11.7.2. Photopheresis
           11.7.3. LDL-apheresis
           11.7.4. Plateletpheresis
           11.7.5. Leukapheresis
           11.7.6. Erythrocytapheresis
           11.7.7. Others 
    11.8. Market Size (US$ Mn) Forecast, By Technology
           11.8.1. Centrifugation
           11.8.2. Membrane filtration
    11.9. Market Size (US$ Mn) Forecast, By End User
           11.9.1.Hospitals 
           11.9.2.Blood Collection Centers
                    11.9.2.1.Public
                    11.9.2.2.private
    11.10. Market Attractiveness Analysis 
           11.10.1. By Country
           11.10.2. By Product Type
           11.10.3. By Application
           11.10.4. By Procedure
           11.10.5. By Technology
           11.10.6. By End User

12.Europe Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
    12.1. Introduction & Definition
    12.2. Key Findings / Developments
    12.3. Key Trends
    12.4. Market Size (US$ Mn) Forecast, By Country
           12.4.1. Germany
           12.4.2. France
           12.4.3. U.K.
           12.4.4. Italy 
           12.4.5. Spain
           12.4.6. Rest of Europe
    12.5. Market Size (US$ Mn) Forecast By Product Type
           12.5.1. Devices
           12.5.2.Disposables
    12.6. Market Size (US$ Mn) Forecast, By Application
           12.6.1. Renal diseases
           12.6.2. Neurology
           12.6.3. Hematology
           12.6.4. Cancer
           12.6.5. Autoimmune disease 
           12.6.6. Cardiovascular diseases 
           12.6.7. Others 
    12.7. Market Size (US$ Mn) Forecast By Procedure
           12.7.1. Plasmapheresis
           12.7.2. Photopheresis
           12.7.3. LDL apheresis
           12.7.4. Plateletpheresis
           12.7.5. Leukapheresis
           12.7.6. Erythrocytapheresis
           12.7.7. Others 
    12.8. Market Size (US$ Mn) Forecast, By Technology
           12.8.1. Centrifugation
           12.8.2. Membrane filtration
    12.9. Market Size (US$ Mn) Forecast, By End User
           12.9.1.Hospitals 
           12.9.2.Blood Collection Centers
                    12.9.2.1.Public
                    12.9.2.2.private
    12.10. Market Attractiveness Analysis 
           12.10.1. By Country
           12.10.2. By Product Type
           12.10.3. By Application
           12.10.4. By Procedure
           12.10.5. By Technology
           12.10.6. By End User

13.Asia Pacific Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
    13.1. Introduction & Definition
    13.2. Key Findings / Developments
    13.3. Key Trends
    13.4. Market Size (US$ Mn) Forecast, By Country
           13.4.1. Japan
           13.4.2. China
           13.4.3. India
           13.4.4. Australia
           13.4.5. Rest of Asia Pacific
    13.5. Market Size (US$ Mn) Forecast By Product Type
           13.5.1. Devices
           13.5.2.Disposables
    13.6. Market Size (US$ Mn) Forecast, By Application
           13.6.1. Renal diseases
           13.6.2. Neurology
           13.6.3. Hematology
           13.6.4. Cancer
           13.6.5. Autoimmune disease 
           13.6.6. Cardiovascular diseases 
           13.6.7. Others 
    13.7. Market Size (US$ Mn) Forecast By Procedure
           13.7.1. Plasmapheresis
           13.7.2. Photopheresis
           13.7.3. LDL-apheresis
           13.7.4. Plateletpheresis
           13.7.5. Leukapheresis
           13.7.6. Erythrocytapheresis
           13.7.7. Others 
    13.8. Market Size (US$ Mn) Forecast, By Technology
           13.8.1. Centrifugation
           13.8.2. Membrane filtration
    13.9. Market Size (US$ Mn) Forecast, By End User
           13.9.1.Hospitals 
           13.9.2.Blood Collection Centers
                    13.9.2.1.Public
                    13.9.2.2.private
    13.10. Market Attractiveness Analysis 
           13.10.1. By Country
           13.10.2. By Product Type
           13.10.3. By Application
           13.10.4. By Procedure
           13.10.5. By Technology
           13.10.6. By End User

14.Latin America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
    14.1. Introduction & Definition
    14.2. Key Findings / Developments
    14.3. Key Trends
    14.4. Market Size (US$ Mn) Forecast, By Country
           14.4.1. Brazil
           14.4.2. Mexico
           14.4.3. Rest of Latin America 
    14.5. Market Size (US$ Mn) Forecast By Product Type
           14.5.1. Devices
           14.5.2.Disposables
    14.6. Market Size (US$ Mn) Forecast, By Application
           14.6.1. Renal diseases
           14.6.2. Neurology
           14.6.3. Hematology
           14.6.4. Cancer
           14.6.5. Autoimmune disease 
           14.6.6. Cardiovascular diseases 
           14.6.7. Others 
    14.7. Market Size (US$ Mn) Forecast By Procedure
           14.7.1. Plasmapheresis
           14.7.2. Photopheresis
           14.7.3. LDL-apheresis
           14.7.4. Plateletpheresis
           14.7.5. Leukapheresis
           14.7.6. Erythrocytapheresis
           14.7.7. Others 
    14.8. Market Size (US$ Mn) Forecast, By Technology
           14.8.1. Centrifugation
           14.8.2. Membrane filtration
    14.9. Market Size (US$ Mn) Forecast, By End User
           14.9.1.Hospitals 
           14.9.2.Blood Collection Centers
                    14.9.2.1.Public
                    14.9.2.2.private
    14.10. Market Attractiveness Analysis 
           14.10.1. By Country
           14.10.2. By Product Type
           14.10.3. By Application
           14.10.4. By Procedure
           14.10.5. By Technology
           14.10.6. By End User

15.Middle East & Africa Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
    15.1. Introduction & Definition
    15.2. Key Findings / Developments
    15.3. Key Trends
    15.4. Market Size (US$ Mn) Forecast, By Country
           15.4.1. Saudi Arabia
           15.4.2. South Africa
           15.4.3. Rest of MEA
    15.5. Market Size (US$ Mn) Forecast By Product Type
           15.5.1. Devices
           15.5.2.Disposables
    15.6. Market Size (US$ Mn) Forecast, By Application
           15.6.1. Renal diseases
           15.6.2. Neurology
           15.6.3. Hematology
           15.6.4. Cancer
           15.6.5. Autoimmune disease 
           15.6.6. Cardiovascular diseases 
           15.6.7. Others
    15.7. Market Size (US$ Mn) Forecast By Procedure
           15.7.1. Plasmapheresis
           15.7.2. Photopheresis
           15.7.3. LDL-apheresis
           15.7.4. Plateletpheresis
           15.7.5. Leukapheresis
           15.7.6. Erythrocytapheresis
           15.7.7. Others
    15.8. Market Size (US$ Mn) Forecast, By Technology
           15.8.1. Centrifugation
           15.8.2. Membrane filtration
    15.9. Market Size (US$ Mn) Forecast, By End User
           15.9.1.Hospitals 
           15.9.2.Blood Collection Centers
                    15.9.2.1.Public
                    15.9.2.2.private
    15.10. Market Attractiveness Analysis 
           15.10.1. By Country
           15.10.2. By Product Type
           15.10.3. By Application
           15.10.4. By Procedure
           15.10.5. By Technology
           15.10.6. By End User

16.Competition Landscape
    16.1. Market Player – Competition Matrix (By Tier and Size of companies)
    16.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
           16.2.1.Asahi Kasei Medical Co., Ltd.
                    16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.1.2. Product Portfolio
                    16.2.1.3. SWOT Analysis
                    16.2.1.4. Financial Overview
                    16.2.1.5. Strategic Overview
           16.2.2. B. Braun Melsungen AG
                    16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.2.2. Product Portfolio
                    16.2.2.3. SWOT Analysis
                    16.2.2.4. Financial Overview
                    16.2.2.5. Strategic Overview
           16.2.3. Cerus Corporation 
                    16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.3.2. Product Portfolio
                    16.2.3.3. SWOT Analysis
                    16.2.3.4. Financial Overview
                    16.2.3.5. Strategic Overview
           16.2.4. Fresenius Medical Care
                    16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.4.2. Product Portfolio
                    16.2.4.3. SWOT Analysis
                    16.2.4.4. Financial Overview
                    16.2.4.5. Strategic Overview
           16.2.5. Haemonetics Corp.
                    16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.5.2. Product Portfolio
                    16.2.5.3. SWOT Analysis
                    16.2.5.4. Financial Overview
                    16.2.5.5. Strategic Overview
           16.2.6. Hemacare Corporation
                    16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.6.2. Product Portfolio
                    16.2.6.3. SWOT Analysis
                    16.2.6.4. Financial Overview
                    16.2.6.5. Strategic Overview
           16.2.7. Kawasumi Laboratories Inc.
                    16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.7.2. Product Portfolio
                    16.2.7.3. SWOT Analysis
                    16.2.7.4. Financial Overview
                    16.2.7.5. Strategic Overview
           16.2.8. Medica S.p.A.
                    16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.8.2. Product Portfolio
                    16.2.8.3. SWOT Analysis
                    16.2.8.4. Financial Overview
                    16.2.8.5. Strategic Overview
           16.2.9. NIKKISO CO., LTD.
                    16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.9.2. Product Portfolio
                    16.2.9.3. SWOT Analysis
                    16.2.9.4. Financial Overview
                    16.2.9.5. Strategic Overview
           16.2.10. Terumo Corporation
                    16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.10.2. Product Portfolio
                    16.2.10.3. SWOT Analysis
                    16.2.10.4. Financial Overview
                    16.2.10.5. Strategic Overview
           16.2.11. Therakos, Inc.
                    16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                    16.2.11.2. Product Portfolio
                    16.2.11.3. SWOT Analysis
                    16.2.11.4. Financial Overview
                    16.2.11.5. Strategic Overview

List of Figures:

Figure 01: Global Apheresis Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 02: Global Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 03: Global Apheresis Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 04: Global Apheresis Disposables Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 05: Global Apheresis Market Attractiveness Analysis, by Product Type
Figure 06: Global Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 07: Global Apheresis in Renal Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 08: Global Apheresis in Neurology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 09: Global Apheresis in Hematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Apheresis in Cancer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: Global Apheresis in Autoimmune Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: Global Apheresis in Cardiovascular Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: Global Apheresis in Other Applications Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: Global Apheresis Market Attractiveness Analysis, by Application
Figure 15: Global Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 16: Global Plasmapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Photopheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global LDL-Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global Plateletpheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Leukapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Erythrocytapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Global Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Procedures, 2015–2025
Figure 23: Global Apheresis Market Attractiveness Analysis, by Procedure
Figure 24: Global Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 25: Global Centrifugation Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: Global Membrane Filtration Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: Global Apheresis Market Attractiveness Analysis, by Technology
Figure 28: Global Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 29: Global Apheresis Market Value Share Analysis, by End-user (blood collection centers), 2016 and 2025
Figure 30: Global Hospitals Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 31: Global Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 32: Global Private Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 33: Global Public Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 34: Global Apheresis Market Attractiveness Analysis, by End-user
Figure 35: Global Apheresis Market Value Share Analysis, by Region, 2016 and 2025
Figure 36: Global Apheresis Market Attractiveness Analysis, by Region
Figure 37: North America Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 38: North America Market Attractiveness Analysis, by Country
Figure 39: North America Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 40: North America Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 41: North America Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 42: North America Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 43: North America Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 44: North America Apheresis Market Value Share Analysis, by End-user (blood collection center), 2016 and 2025
Figure 45: North America Apheresis Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: North America Apheresis Market Attractiveness Analysis, by Product Type
Figure 47: North America Apheresis Market Attractiveness Analysis, by Application
Figure 48: North America Apheresis Market Attractiveness Analysis, by Procedure 
Figure 49: North America Apheresis Market Attractiveness Analysis, by Technology
Figure 50: North America Apheresis Market Attractiveness Analysis, by End-user
Figure 51: Europe Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection, 2017–2025
Figure 52: Europe Apheresis Market Attractiveness Analysis, by Country / Sub-region
Figure 53: Europe Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 54: Europe Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 55: Europe Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 56: Europe Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 57: Europe Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 58: Europe Apheresis Market Value Share Analysis, by End-User (Blood Collection Centers), 2016 and 2025
Figure 59: Europe Apheresis Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
Figure 60: Europe Apheresis Market Attractiveness Analysis, by Product 
Figure 61: Europe Apheresis Market Attractiveness Analysis, by Application
Figure 62: Europe Apheresis Market Attractiveness Analysis, by Procedure 
Figure 63: Europe Apheresis Market Attractiveness Analysis, by Technology
Figure 64: Europe Apheresis Market Attractiveness Analysis, by End-user
Figure 65: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, 2017–2025
Figure 66: Asia Pacific Apheresis Market Attractiveness Analysis, by Country
Figure 67: Asia Pacific Apheresis Market Value Share Analysis, by Product, 2016 and 2025
Figure 68: Asia Pacific Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 69: Asia Pacific Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 70: Asia Pacific Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 71: Asia Pacific Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 72: Asia Pacific Apheresis Market Value Share Analysis, by End-user (Blood Collection Centers), 2016 and 2025
Figure 73: Asia Pacific Apheresis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 74: Asia Pacific Apheresis Market Attractiveness Analysis, by Product 
Figure 75: Asia Pacific Apheresis Market Attractiveness Analysis, by Application
Figure 76: Asia Pacific Apheresis Market Attractiveness Analysis, by Procedure 
Figure 77: Asia Pacific Apheresis Market Attractiveness Analysis, by Technology
Figure 78: Asia Pacific Apheresis Market Attractiveness Analysis, by End-user
Figure 79: Latin America Apheresis Market Size (US$ Mn) Forecast, 2017–2025
Figure 80: Latin America Market Attractiveness Analysis, by Country / Sub-region
Figure 81: Latin America Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 82: Latin America Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 83: Latin America Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 84: Latin America Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 85: Latin America Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 86: Latin America Apheresis Market Value Share Analysis, by End-user (Blood Collection Centers), 2016 and 2025
Figure 87: Latin America Apheresis Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
Figure 88: Latin America Apheresis Market Attractiveness Analysis, by Product 
Figure 89: Latin America Apheresis Market Attractiveness Analysis, by Application
Figure 90: Latin America Apheresis Market Attractiveness Analysis, by Procedure 
Figure 91: Latin America Apheresis Market Attractiveness Analysis, by Technology
Figure 92: Latin America Apheresis Market Attractiveness Analysis, by End-user
Figure 93: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 94: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
Figure 95: Middle East & Africa Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 96: Middle East & Africa Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 97: Middle East & Africa Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 98: Middle East & Africa Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 99: Middle East & Africa Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 100: Middle East & Africa Apheresis Market Value Share Analysis, by End-user (blood collection center), 2016 and 2025
Figure 101: Middle East & Africa Apheresis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 102: Middle East & Africa Apheresis Market Attractiveness Analysis, by Product Type
Figure 103: Middle East & Africa Apheresis Market Attractiveness Analysis, by Application
Figure 104: Middle East & Africa Apheresis Market Attractiveness Analysis, by Procedure 
Figure 105: Middle East & Africa Apheresis Market Attractiveness Analysis, by Technology
Figure 106: Middle East & Africa Apheresis Market Attractiveness Analysis, by End-user

List of Tables:

Table 01: Global Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Global Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 04: Global Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 05: Global Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 06: Global Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
Table 07: Global Apheresis Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 09: North America Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 10: North America Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 11: North America Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 12: North America Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: North America Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
Table 14: North America Apheresis Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Europe Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 16: Europe Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 17: Europe Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 18: Europe Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 19: Europe Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 20: Europe Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
Table 21: Europe Apheresis Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
Table 22: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 23: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 24: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 25: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 26: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 27: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
Table 28: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 29: Latin America Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 30: Latin America Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 31: Latin America Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 32: Latin America Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 33: Latin America Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 34: Latin America Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
Table 35: Latin America Apheresis Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
Table 36: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 37: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 38: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 39: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 40: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 41: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
Table 42: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025

Global Apheresis Market: Overview

Apheresis is a procedure of blood component separation, based on centrifugation and membrane filtration technology. Blood components are separated based on their characteristics such as molecular weight, size, affinity for a particular substance, etc. Blood is withdrawn from patient’s body, an anticoagulant is mixed and the blood components are separated based on their characteristics and specific machine criteria. After removal or separation of the desired blood component remaining of the blood is transfused back to the patient’s body. Apheresis procedures are performed to receive the blood components from a donor which is called as donor apheresis or to treat some disease which is known as therapeutic apheresis. Apheresis procedures are performed across blood collection centers and hospitals. The American Society for Apheresis (ASFA) publishes the guidelines for diseases and indications for performing apheresis procedures. 

Rise in prevalence and incidences of chronic diseases such as multiple sclerosis, cancer, leukemia, etc. has increased the demand for plasma therapeutic products such as immunoglobulin, anti-coagulation factors, albumin, platelets, plasma, etc. In a bid to develop and produce the plasma derived medicines, many of the pharmaceutical and biotechnology industry players are striving for collection of plasma using apheresis procedure or by fractionation of whole blood. These factors has led to rise in donor and therapeutic plasma apheresis procedures driving the growth for global apheresis market. Public and private sector is supporting the apheresis industry in terms of reimbursement and funding, which is projected to uptake use of apheresis across blood collection centers and hospitals. However apheresis procedures are expensive as they incur high capital and operations cost, moreover skilled staff is required to operate apheresis systems which is anticipated to restrain the growth for global apheresis market. 

Global Apheresis Market: Segmentation

Based on product type, global apheresis market is segmented into devices and disposables. Disposables segment which include membrane filtration columns, centrifugation bowls, tubing for blood transfer to and from patient and other disposables. This segment is estimated to dominate the global apheresis market during the forecast period. Based on applications, global apheresis market is segmented into renal diseases, neurology, hematology, cancer, cardiovascular diseases, autoimmune diseases and others. Renal diseases applications are wide and include therapeutic plasma exchange, platelet apheresis and many other apheresis procedures. Neurology applications of apheresis are evidence based and are highly accepted. Other application segments includes rare diseases such as babesiosis and overdose of venoms, diabetes and dermatology diseases. By procedure type, global apheresis market is segmented into plasmapheresis, photopheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis and others. Plasmapheresis is most widely donor and therapeutic apheresis procedure and is projected to dominate the global apheresis market. Other segment of apheresis procedure include procedure such as lymphapheresis, hemopoietic stem cell extraction, and other apheresis procedures. 

Based on technology, global apheresis market is segmented into centrifugation and membrane filtration. Centrifugation based apheresis systems are widely used in North America and Europe region. These systems are more efficient and offer modularity in performing therapeutic apheresis procedures which is projected to drive growth for this segment. By end-user, global apheresis market is segmented into hospitals and blood collection centers. Blood collection centers are further classified into public and private blood collection centers. Public blood collection centers are projected to hold largest share in global apheresis market. Rise in demand for therapeutic apheresis procedure is expected to increase apheresis base in hospitals across the globe. 

Global Apheresis Market: Geographical and Competitive Dynamics

Based on geography, global apheresis market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America was the largest market for apheresis and is projected to continue its dominance during the forecast period from 2017 to 2025. The U.S. contributed largest share in North America apheresis market in 2016. Asia Pacific region is projected to grow exponentially during the forecast period from 2017 to 2025. High prevalence of chronic diseases and increasing healthcare expenditure in emerging markets such as China and India is likely to propel this growth. Europe is projected to hold prominent share in global apheresis market and grow at strong CAGR during the forecast period from 2017 to 2025. 

Companies Mentioned in Report

The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Asahi Kasei Medical Co. Ltd., Terumo Corporation, Haemonetics Corporation, Fresenius Kabi AG, Cerus Corporation, B. Braun Melsungen AG, Kawasumi Laboratories Inc., NIKKISO CO., LTD., Therakos, Inc., and Medica S.p.A. 

The global apheresis market has been segmented as follows:

Global Apheresis Market, by Product Type

  • Devices
  • Disposables 

Global Apheresis Market, by Application

  • Renal diseases
  • Neurology
  • Hematology
  • Cancer
  • Autoimmune disease
  • Cardiovascular diseases
  • Others (e.g. Fibrosis, Diabetes, etc.) 

Global Apheresis Market, by Procedure

  • Plasmapheresis
  • Photopheresis
  • LDL-apheresis
  • Plateletpheresis
  • Leukapheresis
  • Erythrocytapheresis
  • Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.) 

Global Apheresis Market, by Technology

  • Centrifugation
  • Membrane Filtration 

Global Apheresis Market, by End-User

  • Hospitals
  • Blood Collection Centers
  • Public
  • Private 

Global Apheresis Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


 
 
Back To Top